Clonal Hematopoiesis From Next Generation Sequencing of Plasma From a Patient With Lung Adenocarcinoma: A Case Report

Clonal Hematopoiesis From Next Generation Sequencing of Plasma From a Patient With Lung Adenocarcinoma: A Case Report

Reliable and accurate next generation sequencing (NGS) technologies are important in precision medicine. Analysis using currently available NGS genomic tests is conducted on cancer-derived DNA collected from tumor tissue, blood, or both. Clonal hematopoiesis (CH) produces a detectable somatic clonal...

Full description

Bibliographic Details
Main Authors: Munehiro Ito, Yutaka Fujiwara, Takashi Kubo, Hiromichi Matsushita, Tadashi Kumamoto, Tatsuya Suzuki, Kuniko Sunami, Noboru Yamamoto, Takashi Kohno
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Oncology
Subjects:
cell-free DNA
clonal hematopoiesis
next generation sequencing
precision medicine
TP53 mutation
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00113/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00113/full

Similar Items